Abstract：Objective To explore the application of PDCA management mode in the monitoring and management of Chinese patent medicine auxiliary drugs.Methods PDCA cycle management method was used to summarize the current status of the use of proprietary Chinese medicines, summarize problems, find out the reasons, formulate intervention targets and measures, and conduct irrational drug intervention.Statistical analysis was carried out on the use of proprietary Chinese medicines before the implementation of PDCA cycle management (from January to December in 2017)and PDCA cycle management (from January 2018 to June 2019) in our hospital to evaluate the intervention effect and form a normalized management mechanism.Results Since the implementation of PDCA cycle management in 2018, the sales amount of proprietary Chinese medicines in our hospital and its proportion of total sales of medicines had shown a downward trend.The sales amount in 2018 (1152.61 million yuan) was higher than that in 2017 (1931.71 million yuan).The decline was 40.34%.In 2018, the proportion of sales to total sales of medicines (5.05%) decreased by 41.69%compared with 2017 (8.66%).In the first half of 2019, it maintained a downward trend in 2018, reaching the expected intervention target.Conclusion PDCA cycle management can effectively reduce the use of Chinese medicines in hospitals, reduce the burden of patients' drug costs, and promote rational drug use.
曾惠芬; 欧焕娇. PDCA管理模式在中成药类辅助用药监控管理中的应用分析[J]. 中国当代医药, 2020, 27(11): 183-186.
ZENG Hui-fen; OU Huan-jiao. Application analysis of PDCA management mode in the monitoring and management of Chinese patent medicine auxiliary drugs. 中国当代医药, 2020, 27(11): 183-186.
京公网安备 11010502046607号